Cardiovascular Systems, Inc. ($CSII$)’s Piotroski F Score Hits 3893 On the Quant Radar

Cardiovascular Systems, Inc. (CSII) has a Magic Formula rank of 3893.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”. In this book he encourages people to take control of their own money and invest it themselves. Most people entrust their money to investment professionals but Greenblatt observes that most of them don’t beat the market. They make investing sound quite complicated but as Greenblatt explains, it’s actually quite simple. He devised a very straightforward model that can be implemented easily by everyone and has proven to beat the market significantly in the past. Greenblatt suggests purchasing 30 “good companies”: cheap stocks with a high earnings yield and a high return on capital. He touts the success of his magic formula in his book ‘The Little Book that Beats the Market’ citing that it does, in fact, beat the S&P 500 96% of the time, and has averaged a 17-year annual return of 30.8%.

Price Range 52 Weeks

Some of the best financial predictions are formed by using a array of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Cardiovascular Systems, Inc. (CSII) over the past 52 weeks is 0.701339. The 52-week range can be found in the stock’s quote summary.

Enterprise Value

Cardiovascular Systems, Inc. (CSII) based out of United States and resides in the Health Care sector, has a market cap of 1052440.748 after recently touching 34.2 on a recent bid. Cardiovascular Systems, Inc. (CSII) sees an average of trading volume of 6762.9561. Cardiovascular Systems, Inc. (CSII) competes in the Health Care Equipment and Supplies industry.  Watching some historical volatility numbers on shares of Cardiovascular Systems, Inc. (CSII), we can see that the 12 month volatility is currently 38.8058. The 6 month volatility is 48.7354, and the 3 month is spotted at 42.1421. Following volatility data can aid add up how much the stock price has fluctuated over the specified time timeframe. Although past volatility action may aid project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time timeframe. 

Altman Z

Cardiovascular Systems, Inc. (CSII) currently has an Altman Z score of 13.609506. The Z-Score for predicting bankruptcy was published in 1968 by Edward I. Altman, who was assistant professor of finance at New York University at that time. It measures the financial health of a enterprise based on a set of income and balance sheet values. The Altman Z-Score predicts the probability that a firm will go bankrupt within 2 years. In its initial test, the Altman Z-Score was found to be 72% accurate in predicting bankruptcy two years before the event. In a series of subsequent tests, the model was found to be approximately 80%–90% accurate in predicting bankruptcy one year before the event.


EBITDA/EV stands at 0.004337.
This multiple is similar to Earnings Yield, but here we use Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) as Nominator). By doing this, we can compare companies with a different capital structure and capital expenditures. This way it gives a much better idea of the value of a enterprise compared to the trendy P/E ratio. As O’Shaughnessy explaines:

” Stocks that have very high debt levels often have low PE ratios, but this does not necessarily mean that they are cheap in relation to other securities. Stocks that are highly leveraged tend to have far more volatile PE ratios than those that are not. A stock’s PE ratio is greatly affected by debt levels and tax rates, whereas EBITDA/EV is not. To compare valuations on a level playing field, you must account for how a enterprise is financing itself and then compare how relatively cheap or expensive it is after accounting for all balance sheet items.” – James P. O’Shaugnessy in What works on Wall Street

You can think of it as the taking all the revenue and subtracting the costs that solely go into running the business. The downside of EBITDA is that it can be abused by companies declaring as “one-off” costs things that should really be considered normal costs. We use the EBITDA of the last 12 months.

Gazing at some ROIC (Return on Invested Capital) numbers, Cardiovascular Systems, Inc. (CSII)’s ROIC is 0.009464. The ROIC 5 year average is -0.347555. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits. 

Earnings to Price (Yield), Earnings Yield, Earnings Yield Five Year

The Earnings to Price yield of Cardiovascular Systems, Inc. (CSII) is 0.000564. This is determined by taking the EPS and dividing it by the last closing equity price. This is one of the most trendy approaches investors use to check a enterprise’s financial performance. Earnings Yield is determined by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the enterprise. The Earnings Yield for Cardiovascular Systems, Inc. (CSII) is 0.000927. Earnings Yield helps investors add up the return on investment for a given enterprise. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. The Earnings Yield Five Year average for Cardiovascular Systems, Inc. (CSII) is -0.019726.

Leave a Reply

Your email address will not be published. Required fields are marked *